EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) Stock Competitors & Peer Comparison
See FOCL's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for FOCL and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| FOCL | $4.31 | +0.94% | 161.5M | -4.17 | -$1.03 | N/A |
| ABT | $108.93 | -1.30% | 188.5B | 20.91 | $5.21 | +2.27% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| SYK | $317.40 | -4.02% | 124.1B | 24.18 | $13.39 | +1.09% |
| MDT | $92.04 | +1.53% | 117.9B | 16.65 | $5.53 | +3.09% |
| BSX | $48.08 | -0.46% | 71.5B | 15.51 | $3.10 | N/A |
| EW | $90.74 | -0.01% | 52.2B | 33.61 | $2.70 | N/A |
| DXCM | $90.14 | -1.01% | 34B | 35.35 | $2.55 | N/A |
| GEHC | $70.42 | -1.14% | 31.8B | 15.44 | $4.56 | +0.20% |
| PHG | $26.59 | +0.08% | 26B | 15.20 | $1.75 | +3.73% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
FOCL vs ABT Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, ABT has a market cap of 188.5B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while ABT trades at $108.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas ABT's P/E ratio is 20.91. In terms of profitability, FOCL's ROE is -2.90%, compared to ABT's ROE of +0.11%. Regarding short-term risk, FOCL is less volatile compared to ABT. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
FOCL vs BSX-PA Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, FOCL's ROE is -2.90%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, FOCL is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check BSX-PA's competition here
Stryker Corporation (NYSE: SYK)
FOCL vs SYK Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, SYK has a market cap of 124.1B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while SYK trades at $317.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas SYK's P/E ratio is 24.18. In terms of profitability, FOCL's ROE is -2.90%, compared to SYK's ROE of +0.16%. Regarding short-term risk, FOCL is less volatile compared to SYK. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check SYK's competition here
Medtronic plc (NYSE: MDT)
FOCL vs MDT Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, MDT has a market cap of 117.9B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while MDT trades at $92.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas MDT's P/E ratio is 16.65. In terms of profitability, FOCL's ROE is -2.90%, compared to MDT's ROE of +0.14%. Regarding short-term risk, FOCL is less volatile compared to MDT. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
FOCL vs BSX Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, BSX has a market cap of 71.5B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while BSX trades at $48.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas BSX's P/E ratio is 15.51. In terms of profitability, FOCL's ROE is -2.90%, compared to BSX's ROE of +0.15%. Regarding short-term risk, FOCL is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
FOCL vs EW Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, EW has a market cap of 52.2B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while EW trades at $90.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas EW's P/E ratio is 33.61. In terms of profitability, FOCL's ROE is -2.90%, compared to EW's ROE of +0.10%. Regarding short-term risk, FOCL is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
FOCL vs DXCM Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, DXCM has a market cap of 34B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while DXCM trades at $90.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas DXCM's P/E ratio is 35.35. In terms of profitability, FOCL's ROE is -2.90%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, FOCL is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
FOCL vs GEHC Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, GEHC has a market cap of 31.8B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while GEHC trades at $70.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas GEHC's P/E ratio is 15.44. In terms of profitability, FOCL's ROE is -2.90%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, FOCL is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
FOCL vs PHG Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, PHG has a market cap of 26B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while PHG trades at $26.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas PHG's P/E ratio is 15.20. In terms of profitability, FOCL's ROE is -2.90%, compared to PHG's ROE of +0.10%. Regarding short-term risk, FOCL is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
FOCL vs ZBH Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, ZBH has a market cap of 19.2B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while ZBH trades at $99.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas ZBH's P/E ratio is 11.72. In terms of profitability, FOCL's ROE is -2.90%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, FOCL is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
FOCL vs ABMD Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas ABMD's P/E ratio is 65.36. In terms of profitability, FOCL's ROE is -2.90%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, FOCL is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
FOCL vs PEN Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, PEN has a market cap of 12.7B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while PEN trades at $322.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas PEN's P/E ratio is 84.26. In terms of profitability, FOCL's ROE is -2.90%, compared to PEN's ROE of +0.11%. Regarding short-term risk, FOCL is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
FOCL vs SWAV Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas SWAV's P/E ratio is 78.76. In terms of profitability, FOCL's ROE is -2.90%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, FOCL is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check SWAV's competition here
Smith & Nephew plc (NYSE: SNN)
FOCL vs SNN Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, SNN has a market cap of 12.2B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while SNN trades at $28.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas SNN's P/E ratio is 13.62. In terms of profitability, FOCL's ROE is -2.90%, compared to SNN's ROE of +0.12%. Regarding short-term risk, FOCL is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
FOCL vs ALGN Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, ALGN has a market cap of 11.1B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while ALGN trades at $154.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas ALGN's P/E ratio is 14.13. In terms of profitability, FOCL's ROE is -2.90%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, FOCL is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check ALGN's competition here
Globus Medical, Inc. (NYSE: GMED)
FOCL vs GMED Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, GMED has a market cap of 10.8B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while GMED trades at $80.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas GMED's P/E ratio is 18.12. In terms of profitability, FOCL's ROE is -2.90%, compared to GMED's ROE of +0.12%. Regarding short-term risk, FOCL is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check GMED's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
FOCL vs BIO-B Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, BIO-B has a market cap of 10.4B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while BIO-B trades at $381.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas BIO-B's P/E ratio is -67.15. In terms of profitability, FOCL's ROE is -2.90%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, FOCL is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check BIO-B's competition here
Glaukos Corporation (NYSE: GKOS)
FOCL vs GKOS Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, GKOS has a market cap of 10.4B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while GKOS trades at $176.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas GKOS's P/E ratio is -205.42. In terms of profitability, FOCL's ROE is -2.90%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, FOCL is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check GKOS's competition here
Insulet Corp. (NASDAQ: PODD)
FOCL vs PODD Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, PODD has a market cap of 10.3B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while PODD trades at $148.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas PODD's P/E ratio is 25.28. In terms of profitability, FOCL's ROE is -2.90%, compared to PODD's ROE of +0.27%. Regarding short-term risk, FOCL is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check PODD's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
FOCL vs BIO Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, BIO has a market cap of 10.2B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while BIO trades at $380.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas BIO's P/E ratio is 41.02. In terms of profitability, FOCL's ROE is -2.90%, compared to BIO's ROE of +0.03%. Regarding short-term risk, FOCL is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check BIO's competition here
Masimo Corporation (NASDAQ: MASI)
FOCL vs MASI Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas MASI's P/E ratio is 44.43. In terms of profitability, FOCL's ROE is -2.90%, compared to MASI's ROE of +0.09%. Regarding short-term risk, FOCL is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
FOCL vs BRKR Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, BRKR has a market cap of 8.5B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while BRKR trades at $56.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas BRKR's P/E ratio is 28.16. In terms of profitability, FOCL's ROE is -2.90%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, FOCL is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
FOCL vs BRKRP Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, BRKRP has a market cap of 8.3B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while BRKRP trades at $415.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas BRKRP's P/E ratio is 224.70. In terms of profitability, FOCL's ROE is -2.90%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, FOCL is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check BRKRP's competition here
Inari Medical, Inc. (NASDAQ: NARI)
FOCL vs NARI Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas NARI's P/E ratio is -59.24. In terms of profitability, FOCL's ROE is -2.90%, compared to NARI's ROE of -0.00%. Regarding short-term risk, FOCL is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check NARI's competition here
Haemonetics Corporation (NYSE: HAE)
FOCL vs HAE Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, HAE has a market cap of 4.6B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while HAE trades at $101.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas HAE's P/E ratio is 20.35. In terms of profitability, FOCL's ROE is -2.90%, compared to HAE's ROE of +0.11%. Regarding short-term risk, FOCL is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check HAE's competition here
LivaNova PLC (NASDAQ: LIVN)
FOCL vs LIVN Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, LIVN has a market cap of 4.4B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while LIVN trades at $80.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas LIVN's P/E ratio is 19.04. In terms of profitability, FOCL's ROE is -2.90%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, FOCL is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check LIVN's competition here
Integer Holdings Corporation (NYSE: ITGR)
FOCL vs ITGR Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while ITGR trades at $125.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas ITGR's P/E ratio is 19.76. In terms of profitability, FOCL's ROE is -2.90%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, FOCL is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check ITGR's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
FOCL vs IRTC Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, IRTC has a market cap of 4B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while IRTC trades at $122.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas IRTC's P/E ratio is -284.53. In terms of profitability, FOCL's ROE is -2.90%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, FOCL is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
FOCL vs AXNX Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas AXNX's P/E ratio is -709.80. In terms of profitability, FOCL's ROE is -2.90%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, FOCL is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
FOCL vs TMDX Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, TMDX has a market cap of 2.8B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while TMDX trades at $82.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas TMDX's P/E ratio is 41.75. In terms of profitability, FOCL's ROE is -2.90%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, FOCL is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
FOCL vs AXGN Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, AXGN has a market cap of 2.7B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while AXGN trades at $49.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas AXGN's P/E ratio is 131.26. In terms of profitability, FOCL's ROE is -2.90%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, FOCL is more volatile compared to AXGN. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check AXGN's competition here
Neogen Corporation (NASDAQ: NEOG)
FOCL vs NEOG Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, NEOG has a market cap of 2.5B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while NEOG trades at $11.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas NEOG's P/E ratio is 41.57. In terms of profitability, FOCL's ROE is -2.90%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, FOCL is more volatile compared to NEOG. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check NEOG's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
FOCL vs UFPT Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, UFPT has a market cap of 2.3B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while UFPT trades at $294.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas UFPT's P/E ratio is 30.04. In terms of profitability, FOCL's ROE is -2.90%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, FOCL is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check UFPT's competition here
Butterfly Network, Inc. (NYSE: BFLY)
FOCL vs BFLY Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, BFLY has a market cap of 2.2B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while BFLY trades at $8.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas BFLY's P/E ratio is -34.10. In terms of profitability, FOCL's ROE is -2.90%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, FOCL is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check BFLY's competition here
NuVasive, Inc. (NASDAQ: NUVA)
FOCL vs NUVA Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas NUVA's P/E ratio is 75.00. In terms of profitability, FOCL's ROE is -2.90%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, FOCL is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check NUVA's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
FOCL vs ESTA Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, ESTA has a market cap of 2B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while ESTA trades at $69.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas ESTA's P/E ratio is -55.20. In terms of profitability, FOCL's ROE is -2.90%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, FOCL is more volatile compared to ESTA. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check ESTA's competition here
Novocure Ltd (NASDAQ: NVCR)
FOCL vs NVCR Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, NVCR has a market cap of 2B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while NVCR trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas NVCR's P/E ratio is -13.37. In terms of profitability, FOCL's ROE is -2.90%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, FOCL is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check NVCR's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
FOCL vs INSP Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, INSP has a market cap of 1.8B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while INSP trades at $61.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas INSP's P/E ratio is 27.10. In terms of profitability, FOCL's ROE is -2.90%, compared to INSP's ROE of +0.18%. Regarding short-term risk, FOCL is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check INSP's competition here
CONMED Corporation (NYSE: CNMD)
FOCL vs CNMD Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while CNMD trades at $49.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas CNMD's P/E ratio is 10.80. In terms of profitability, FOCL's ROE is -2.90%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, FOCL is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check CNMD's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
FOCL vs TNDM Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, TNDM has a market cap of 1.5B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while TNDM trades at $21.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas TNDM's P/E ratio is -22.88. In terms of profitability, FOCL's ROE is -2.90%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, FOCL is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check TNDM's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
FOCL vs ATEC Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, ATEC has a market cap of 1.4B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while ATEC trades at $9.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas ATEC's P/E ratio is -153.50. In terms of profitability, FOCL's ROE is -2.90%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, FOCL is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check ATEC's competition here
Artivion, Inc. (NYSE: AORT)
FOCL vs AORT Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, AORT has a market cap of 1.3B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while AORT trades at $27.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas AORT's P/E ratio is 45.22. In terms of profitability, FOCL's ROE is -2.90%, compared to AORT's ROE of -0.01%. Regarding short-term risk, FOCL is more volatile compared to AORT. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check AORT's competition here
Heska Corporation (NASDAQ: HSKA)
FOCL vs HSKA Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas HSKA's P/E ratio is -62.49. In terms of profitability, FOCL's ROE is -2.90%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, FOCL is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
FOCL vs IART Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while IART trades at $16.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas IART's P/E ratio is 7.04. In terms of profitability, FOCL's ROE is -2.90%, compared to IART's ROE of -0.01%. Regarding short-term risk, FOCL is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check IART's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
FOCL vs PRCT Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while PRCT trades at $20.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas PRCT's P/E ratio is -10.78. In terms of profitability, FOCL's ROE is -2.90%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, FOCL is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check PRCT's competition here
Enovis Corporation (NYSE: ENOV)
FOCL vs ENOV Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, ENOV has a market cap of 1.2B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while ENOV trades at $20.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas ENOV's P/E ratio is 5.88. In terms of profitability, FOCL's ROE is -2.90%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, FOCL is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check ENOV's competition here
Avanos Medical, Inc. (NYSE: AVNS)
FOCL vs AVNS Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas AVNS's P/E ratio is 27.77. In terms of profitability, FOCL's ROE is -2.90%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, FOCL is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check AVNS's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
FOCL vs LMRI Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while LMRI trades at $11.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas LMRI's P/E ratio is -22.65. In terms of profitability, FOCL's ROE is -2.90%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, FOCL is more volatile compared to LMRI. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check LMRI's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
FOCL vs SILK Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas SILK's P/E ratio is -18.96. In terms of profitability, FOCL's ROE is -2.90%, compared to SILK's ROE of -0.35%. Regarding short-term risk, FOCL is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check SILK's competition here
IRadimed Corporation (NASDAQ: IRMD)
FOCL vs IRMD Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while IRMD trades at $86.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas IRMD's P/E ratio is 43.41. In terms of profitability, FOCL's ROE is -2.90%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, FOCL is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check IRMD's competition here
Paragon 28, Inc. (NYSE: FNA)
FOCL vs FNA Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas FNA's P/E ratio is -19.83. In terms of profitability, FOCL's ROE is -2.90%, compared to FNA's ROE of -0.35%. Regarding short-term risk, FOCL is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check FNA's competition here
CeriBell, Inc. (NASDAQ: CBLL)
FOCL vs CBLL Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, CBLL has a market cap of 932.6M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while CBLL trades at $24.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas CBLL's P/E ratio is -13.97. In terms of profitability, FOCL's ROE is -2.90%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, FOCL is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check CBLL's competition here
Bioventus Inc. (NASDAQ: BVS)
FOCL vs BVS Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, BVS has a market cap of 926.1M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while BVS trades at $13.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas BVS's P/E ratio is 17.99. In terms of profitability, FOCL's ROE is -2.90%, compared to BVS's ROE of +0.28%. Regarding short-term risk, FOCL is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check BVS's competition here
InMode Ltd. (NASDAQ: INMD)
FOCL vs INMD Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, INMD has a market cap of 863.9M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while INMD trades at $15.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas INMD's P/E ratio is 10.44. In terms of profitability, FOCL's ROE is -2.90%, compared to INMD's ROE of +0.12%. Regarding short-term risk, FOCL is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check INMD's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
FOCL vs BBNX Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, BBNX has a market cap of 858M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while BBNX trades at $19.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas BBNX's P/E ratio is -11.56. In terms of profitability, FOCL's ROE is -2.90%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, FOCL is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check BBNX's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
FOCL vs CSII Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas CSII's P/E ratio is -20.83. In terms of profitability, FOCL's ROE is -2.90%, compared to CSII's ROE of -0.14%. Regarding short-term risk, FOCL is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
FOCL vs SIBN Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, SIBN has a market cap of 839.1M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while SIBN trades at $18.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas SIBN's P/E ratio is -55.65. In terms of profitability, FOCL's ROE is -2.90%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, FOCL is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check SIBN's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
FOCL vs AVR Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, AVR has a market cap of 821.6M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while AVR trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas AVR's P/E ratio is -4.36. In terms of profitability, FOCL's ROE is -2.90%, compared to AVR's ROE of -0.78%. Regarding short-term risk, FOCL is more volatile compared to AVR. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check AVR's competition here
Varex Imaging Corporation (NASDAQ: VREX)
FOCL vs VREX Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, VREX has a market cap of 777.6M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while VREX trades at $18.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas VREX's P/E ratio is 19.44. In terms of profitability, FOCL's ROE is -2.90%, compared to VREX's ROE of +0.05%. Regarding short-term risk, FOCL is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check VREX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
FOCL vs AHCO Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, AHCO has a market cap of 749.7M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while AHCO trades at $5.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas AHCO's P/E ratio is 11.24. In terms of profitability, FOCL's ROE is -2.90%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, FOCL is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check AHCO's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
FOCL vs SSII Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, SSII has a market cap of 668.4M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while SSII trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas SSII's P/E ratio is -65.15. In terms of profitability, FOCL's ROE is -2.90%, compared to SSII's ROE of -0.27%. Regarding short-term risk, FOCL is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check SSII's competition here
Surmodics, Inc. (NASDAQ: SRDX)
FOCL vs SRDX Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas SRDX's P/E ratio is -34.66. In terms of profitability, FOCL's ROE is -2.90%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, FOCL is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check SRDX's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
FOCL vs CTKB Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, CTKB has a market cap of 596.6M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while CTKB trades at $4.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas CTKB's P/E ratio is -24.48. In terms of profitability, FOCL's ROE is -2.90%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, FOCL is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check CTKB's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
FOCL vs KIDS Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, KIDS has a market cap of 590.8M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while KIDS trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas KIDS's P/E ratio is -19.49. In terms of profitability, FOCL's ROE is -2.90%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, FOCL is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check KIDS's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
FOCL vs APEN Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas APEN's P/E ratio is -9.43. In terms of profitability, FOCL's ROE is -2.90%, compared to APEN's ROE of -0.85%. Regarding short-term risk, FOCL is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check APEN's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
FOCL vs DCTH Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, DCTH has a market cap of 566.2M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while DCTH trades at $16.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas DCTH's P/E ratio is 1640.00. In terms of profitability, FOCL's ROE is -2.90%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, FOCL is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
FOCL vs ZIMV Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, FOCL's ROE is -2.90%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, FOCL is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check ZIMV's competition here
Cerus Corporation (NASDAQ: CERS)
FOCL vs CERS Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, CERS has a market cap of 526M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while CERS trades at $2.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas CERS's P/E ratio is -52.10. In terms of profitability, FOCL's ROE is -2.90%, compared to CERS's ROE of -0.10%. Regarding short-term risk, FOCL is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check CERS's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
FOCL vs TCMD Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, TCMD has a market cap of 518.3M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while TCMD trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas TCMD's P/E ratio is 21.28. In terms of profitability, FOCL's ROE is -2.90%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, FOCL is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check TCMD's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
FOCL vs NPCE Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, NPCE has a market cap of 502.5M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while NPCE trades at $14.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas NPCE's P/E ratio is -25.86. In terms of profitability, FOCL's ROE is -2.90%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, FOCL is more volatile compared to NPCE. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check NPCE's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
FOCL vs CLPT Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, CLPT has a market cap of 446.8M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while CLPT trades at $14.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas CLPT's P/E ratio is -12.63. In terms of profitability, FOCL's ROE is -2.90%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, FOCL is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check CLPT's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
FOCL vs SGHT Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, SGHT has a market cap of 445.6M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while SGHT trades at $8.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas SGHT's P/E ratio is -14.62. In terms of profitability, FOCL's ROE is -2.90%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, FOCL is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check SGHT's competition here
Carlsmed, Inc. (NASDAQ: CARL)
FOCL vs CARL Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, CARL has a market cap of 445M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while CARL trades at $16.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas CARL's P/E ratio is -11.45. In terms of profitability, FOCL's ROE is -2.90%, compared to CARL's ROE of -0.38%. Regarding short-term risk, FOCL is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check CARL's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
FOCL vs PACB Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, PACB has a market cap of 397.6M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while PACB trades at $1.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas PACB's P/E ratio is -3.12. In terms of profitability, FOCL's ROE is -2.90%, compared to PACB's ROE of -49.62%. Regarding short-term risk, FOCL is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check PACB's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
FOCL vs SENS Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, SENS has a market cap of 392M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while SENS trades at $9.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas SENS's P/E ratio is -4.21. In terms of profitability, FOCL's ROE is -2.90%, compared to SENS's ROE of -1.66%. Regarding short-term risk, FOCL is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
FOCL vs OFIX Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, OFIX has a market cap of 381.2M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while OFIX trades at $9.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas OFIX's P/E ratio is -6.14. In terms of profitability, FOCL's ROE is -2.90%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, FOCL is more volatile compared to OFIX. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check OFIX's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
FOCL vs CATX Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, CATX has a market cap of 355.3M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while CATX trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas CATX's P/E ratio is -2.34. In terms of profitability, FOCL's ROE is -2.90%, compared to CATX's ROE of -0.42%. Regarding short-term risk, FOCL is more volatile compared to CATX. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check CATX's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
FOCL vs TLSI Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, TLSI has a market cap of 318.3M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while TLSI trades at $5.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas TLSI's P/E ratio is -3.08. In terms of profitability, FOCL's ROE is -2.90%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, FOCL is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check TLSI's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
FOCL vs SMLR Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas SMLR's P/E ratio is 3.92. In terms of profitability, FOCL's ROE is -2.90%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, FOCL is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
FOCL vs TMCI Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, TMCI has a market cap of 298.4M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while TMCI trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas TMCI's P/E ratio is -4.89. In terms of profitability, FOCL's ROE is -2.90%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, FOCL is more volatile compared to TMCI. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check TMCI's competition here
CapsoVision, Inc. (NASDAQ: CV)
FOCL vs CV Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, CV has a market cap of 293.3M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while CV trades at $5.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas CV's P/E ratio is -2.35. In terms of profitability, FOCL's ROE is -2.90%, compared to CV's ROE of -1.78%. Regarding short-term risk, FOCL is more volatile compared to CV. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check CV's competition here
RxSight, Inc. (NASDAQ: RXST)
FOCL vs RXST Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, RXST has a market cap of 289.4M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while RXST trades at $6.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas RXST's P/E ratio is -6.19. In terms of profitability, FOCL's ROE is -2.90%, compared to RXST's ROE of -0.17%. Regarding short-term risk, FOCL is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check RXST's competition here
Avita Medical Inc. (NASDAQ: RCEL)
FOCL vs RCEL Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, RCEL has a market cap of 250.2M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while RCEL trades at $10.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas RCEL's P/E ratio is -6.99. In terms of profitability, FOCL's ROE is -2.90%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, FOCL is more volatile compared to RCEL. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check RCEL's competition here
Profound Medical Corp. (NASDAQ: PROF)
FOCL vs PROF Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, PROF has a market cap of 247.1M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while PROF trades at $6.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas PROF's P/E ratio is -6.94. In terms of profitability, FOCL's ROE is -2.90%, compared to PROF's ROE of -0.56%. Regarding short-term risk, FOCL is more volatile compared to PROF. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check PROF's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
FOCL vs MGRM Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas MGRM's P/E ratio is -12.00. In terms of profitability, FOCL's ROE is -2.90%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, FOCL is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check MGRM's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
FOCL vs INFU Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, INFU has a market cap of 243.6M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while INFU trades at $12.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas INFU's P/E ratio is 29.44. In terms of profitability, FOCL's ROE is -2.90%, compared to INFU's ROE of +0.15%. Regarding short-term risk, FOCL is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check INFU's competition here
Nevro Corp. (NYSE: NVRO)
FOCL vs NVRO Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas NVRO's P/E ratio is -1.91. In terms of profitability, FOCL's ROE is -2.90%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, FOCL is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check NVRO's competition here
Electromed, Inc. (AMEX: ELMD)
FOCL vs ELMD Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, ELMD has a market cap of 223.8M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while ELMD trades at $27.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas ELMD's P/E ratio is 20.63. In terms of profitability, FOCL's ROE is -2.90%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, FOCL is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check ELMD's competition here
Neuronetics, Inc. (NASDAQ: STIM)
FOCL vs STIM Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, STIM has a market cap of 197.6M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while STIM trades at $2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas STIM's P/E ratio is -6.45. In terms of profitability, FOCL's ROE is -2.90%, compared to STIM's ROE of -1.51%. Regarding short-term risk, FOCL is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check STIM's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
FOCL vs BSGM Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas BSGM's P/E ratio is -5.81. In terms of profitability, FOCL's ROE is -2.90%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, FOCL is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check BSGM's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
FOCL vs LUCD Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, LUCD has a market cap of 185.8M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while LUCD trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas LUCD's P/E ratio is -2.63. In terms of profitability, FOCL's ROE is -2.90%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, FOCL is more volatile compared to LUCD. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check LUCD's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
FOCL vs MDGS Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas MDGS's P/E ratio is -0.27. In terms of profitability, FOCL's ROE is -2.90%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, FOCL is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check MDGS's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
FOCL vs QIPT Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas QIPT's P/E ratio is -15.87. In terms of profitability, FOCL's ROE is -2.90%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, FOCL is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check QIPT's competition here
Quantum-Si incorporated (NASDAQ: QSI)
FOCL vs QSI Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, QSI has a market cap of 149.8M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while QSI trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas QSI's P/E ratio is -1.65. In terms of profitability, FOCL's ROE is -2.90%, compared to QSI's ROE of -0.47%. Regarding short-term risk, FOCL is more volatile compared to QSI. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check QSI's competition here
Inogen, Inc. (NASDAQ: INGN)
FOCL vs INGN Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, INGN has a market cap of 144.3M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while INGN trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas INGN's P/E ratio is -5.86. In terms of profitability, FOCL's ROE is -2.90%, compared to INGN's ROE of -0.13%. Regarding short-term risk, FOCL is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
FOCL vs QTRX Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, QTRX has a market cap of 118.2M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while QTRX trades at $2.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas QTRX's P/E ratio is -0.99. In terms of profitability, FOCL's ROE is -2.90%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, FOCL is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check QTRX's competition here
iCAD, Inc. (NASDAQ: ICAD)
FOCL vs ICAD Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas ICAD's P/E ratio is -20.37. In terms of profitability, FOCL's ROE is -2.90%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, FOCL is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check ICAD's competition here
LENSAR Inc (NASDAQ: LNSR)
FOCL vs LNSR Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, LNSR has a market cap of 103.9M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while LNSR trades at $8.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas LNSR's P/E ratio is 8.63. In terms of profitability, FOCL's ROE is -2.90%, compared to LNSR's ROE of +103.80%. Regarding short-term risk, FOCL is more volatile compared to LNSR. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check LNSR's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
FOCL vs HJLI Comparison September 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 161.5M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, FOCL is priced at $4.31 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -4.17, whereas HJLI's P/E ratio is N/A. In terms of profitability, FOCL's ROE is -2.90%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, FOCL is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check HJLI's competition here